CARsgen Therapeutics Co.
Latest round
- Series C
Last raised
- Jan 2021
Total raised
- $286M
Investors
- 12
About CARsgen Therapeutics Co.
, Ltd. operates as a biopharmaceutical company that focuses on chimeric antigen receptor t-cell(CAR-T) cell therapy to treat hematomas and solid tumors. The company provides cell therapy platform that includes target discovery, lead antibody development, clinical research and commercial scale production. The product of the company includes manand biosphere programme(mAb) and the regular, next generation and Allogeneic of cell therapy products, such as AB011, KJ-C2112 and CT011. The company develops cytokine and chemokine loaded CAR(CycloCAR), target to hinder the attack of nk cell(THANK)-uCAR and whole human anti-phage display technology. The company has 7 investigational new drug(IND)licenses.
Who invested in CARsgen Therapeutics Co.
12 investors across 5 rounds
See all investors in CARsgen Therapeutics Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CARsgen Therapeutics Co.
Who invested in CARsgen Therapeutics Co.?
CARsgen Therapeutics Co. has 12 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CARsgen Therapeutics Co. raised?
CARsgen Therapeutics Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did CARsgen Therapeutics Co. last raise money?
CARsgen Therapeutics Co.'s most recent round on record is a Series C, in Jan 2021.
What does CARsgen Therapeutics Co. do?
CARsgen Therapeutics Co. is a biotechnology company.
Where is CARsgen Therapeutics Co. headquartered?
CARsgen Therapeutics Co. is headquartered in Shanghai, China.
Which VCs invest in companies like CARsgen Therapeutics Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at CARsgen Therapeutics Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like CARsgen Therapeutics Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.